Changes in the Ulnar Tissues by Shear-wave Elastography

August 31, 2018 updated by: J. Nicolas Cuenca Zaldivar, Guadarrama Hospital

Changes in the Tension of the Flexor Carpi Ulnar Muscle With the Tensioning of the Ulnar Nerve by Shear-wave Elastography: a Pilot Study

A single-center, observational, prospective, single cohort study with before-after design. Evaluation by shear-wave elastography, measured in kilopascals (KPa), of the muscle, tendon and cubital nerve, before and after the maneuver of putting in tension of the ulnar nerve.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Detailed Description

Once each subject has signed the informed consent document and it has been verified that the inclusion criteria are met, it will be assigned the same identification number (ID) that is related to its Clinical History (CH) by simple coding; custody of the file with the relationship of each ID with its CH will be the responsibility of the principal investigator.

Body placement: The participants will be placed in the supine position with the hips and knees bent, in such a way that the soles of the feet rest on the plane of the stretcher. the palm of the hand of the left extremity will rest on the abdomen and the head in a neutral position, with the maximum relaxation of the sternocleidomastoids.

Upper limb placement: The right extremity will be placed in abduction of 90°, the elbow to flexion of 10° and the forearm to 30° of supination. Wrist and joints metacarpophalangic (mcf), proximal interphalangeal (ifp) and distal interphalangeal (ifp) of the first three fingers in full extension. The articulations mcf, ifp, ifd of the fourth and fifth fingers in a relaxed position. In this position, the first ultrasound measurement will be taken.

Tension maneuver of the ulnar nerve: An expert researcher in mobilization of neural tissue will perform an extension of fourth and fifth finger, respecting the initial parameters that are maintained in position by the splint. To do this, he will use the index and middle of his left hand and make a contact on the palmar side of the fingers and a back pressure with the thumb on the back of the hand. Next, it will extend the fingers until the exponential resistance following the path of elastic deformation (linear resistance) of the tensioned tissues is perceived. At this time the new ultrasound record will be made.

Ultrasound records: A Toshiba ai800 ultrasound scanner (Toshiba Medical Corporation, Japan) with a multifrequency linear probe plt-1005bt 14l5 (5-14 Mhz) will be used. The identification number (ID) registered in the ultrasound will correspond to the participant number.

The same researcher, with experience in the acquisition and management of medical images, will perform the ultrasound and in-line measurements of the images obtained.

The ultrasound will be obtained in a pre and post-median situation after the neural tension put on by the expert investigator in manual therapy and a label will be consigned in the images indicating if the acquisition was "pre" or "post".

To perform the acquisition of the images the probe wil be positioned on the skin of the forearm with minimal pressure and with angulation such that there is no anisotropy. The anatomical region where the myotendinous junction of the flexor carpi ulnaris muscle and the ulnar nerve is observed will be searched transversally. the parameters of emission power, general gain, depth of the image, position of the focus and frequency of emission will be adapted to obtain a quality image. The protocol will be the following:

  • 2d image in transverse plane.
  • 2d image in longitudinal plane.
  • Shear-wave elastography in longitudinal plane.
  • Measurement of the images: They will be carried out off-line using the elastography software of the team itself once all the participants have been explored. three regions of interest (ROIs) adjacent to each other will be established in the body of the ulnar nerve, three in the distal area of the flexor carpi ulnaris muscle and three in the tendinous body of the same muscle. The size of the ROI should include the entire body of the mentioned structures.
  • The average value of the three ROIs will be written down in units of pressure (KPa).

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
39

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Spain
    • Madrid
      • Guadarrama, Madrid, Spain, 28440
        • J.Nicolas Cuenca Zaldivar

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 26 years (ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Healthy volunteers recruited among the students of the Francisco de Vitoria University.

Description

Inclusion Criteria:

  • Francisco de Vitoria University student.
  • Age between 18 and 26 years old.

Exclusion Criteria:

  • History of neuropathies in upper limbs.
  • Slight neck pain in the last 6 months of traumatic origin.
  • Neck pain in the last 3 months.
  • episodes of moderate / severe neck pain in the last year.
  • History of fracture or dislocation in the upper extremity.
  • Surgical history in the upper extremity.
  • Cervical symptomatology or upper limb at the present time.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
elastographic soft tissue tension (KPa)
Time Frame: 1 day
Tension (KPa) in the nerve, muscle and ulnar tendon measured by elastography shear-wave before and after putting the ulnar nerve in tension
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Guadarrama Hospital

Collaborators

Collaborators

An organization other than the sponsor that provides support for a clinical study. This support may include activities related to funding, design, implementation, data analysis, or reporting.
Universidad Francisco de Vitoria

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
May 1, 2018

Primary Completion (ACTUAL)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
July 1, 2018

Study Completion (ACTUAL)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
July 1, 2018

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 17, 2018

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 17, 2018

First Posted (ACTUAL)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 26, 2018

Study Record Updates

Last Update Posted (ACTUAL)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
September 4, 2018

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 31, 2018

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2018

More Information

Terms related to this study

Keywords

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 3.0

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The statistical analysis plan and the analytical code will be available in .html and .rmd format as well as the file with the raw data.

IPD Sharing Time Frame

The data will be available permanently once the statistical analysis is complete.

IPD Sharing Access Criteria

The data will be available freely and publicly.

IPD Sharing Supporting Information Type

  • SAP
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Elastography

Clinical Trials on shear-wave elastography

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings